Helaina
Edit

Helaina

https://www.myhelaina.com/home
Last activity: 02.09.2026
Active
Categories: BioTechFamilyFoodTechHealthTechHumanPersonalProduct
Helaina is a breastfeeding support company commercializing the world's first nature-identical infant milk.
Followers
2.03K
Website visits
35K /mo.
Mentions
27
Location: United States, New York
Employees: 11-50
Total raised: $65M

Investors 6

Funding Rounds 2

DateSeriesAmountInvestors
26.09.2024Series B$45M-
19.11.2021Series A$20M-

Mentions in press and media 27

DateTitleDescription
02.09.2026French Govt Invests €3.7M in Nūmi to Scale Up Cell-Cultured Breast Milk4 Mins Read Parisian startup Nūmi, which is developing cell-based breast milk, has secured €3.7M ($4.3M) in non-dilutive funding from the French government after being selected as a France 2030 i-Démo laureate. French cellular agriculture p...
23.07.2026All G Debuts Cow-Free Lactoferrin in US, with Human-Identical Protein Launch Imminent6 Mins Read Australian startup All G has launched its precision-fermented bovine lactoferrin in the US, just as it plans a second facility and expects to bring its human lactoferrin ingredient to market within six months. Months after secur...
23.07.2026All G makes US debut with low-iron lactoferrin made via precision fermentationAustralian startup All G has made its US debut with LFX apo-lactoferrin, bovine-equivalent lactoferrin made via precision fermentation with less than 5% iron saturation. An iron-binding anti-microbial protein found in mammalian milk, lactof...
08.07.2026Novonesis Invests in TurtleTree to Scale Up Cow-Free Lactoferrin for Early Nutrition5 Mins Read Danish biotech giant Novonesis has signed an exclusive deal to scale up and commercialise TurtleTree’s precision-fermented lactoferrin protein, following investment in the Singaporean startup. Singapore’s TurtleTree has taken a ...
03.06.2026Nestlé taps Helaina to explore bioactive proteins in infant nutritionNestlé and Helaina—a New York-based startup making bioactive found in human breastmilk via precision fermentation—have formed a multi-year partnership to expand understanding of the role of bioactive proteins in early‑life development. Hela...
21.07.202510 million servings per run: Helaina scales human lactoferrin productionNew York-based startup Helaina has scaled up production capacity for its precision fermented human lactoferrin (brand name: effera) with co-manufacturing partners to the scale of metric tons. “That’s 10 million servings of product per produ...
26.09.2024Helaina's $45 Million Leap: Revolutionizing Nutrition with Human LactoferrinIn the bustling world of biotechnology, Helaina stands out like a lighthouse in a storm. This New York-based startup has just raised $45 million in a Series B funding round, a significant boost that brings its total equity funding to $83 mi...
26.09.2024Helaina Raises $45M to Commercialize First Precision-Fermented Human LactoferrinUS precision fermentation company Helaina has raised $45 million in Series B funding to scale and commercialize its first product, effera Human Lactoferrin. Effera, claimed to be the first and only human lactoferrin available, is a bioactiv...
25.09.2024Helaina Raises $45M in Series B FundingHelaina, a NYC-based biotechnology company developing human equivalent bioactive proteins, raised $45M in Series B funding. The round, which brought the total amount to $83M, was led by Avidity Partners, with additional investment from Spar...
25.09.2024Helaina raises $45m series B round to support market entry of human lactoferrinNew York-based Helaina—a startup using precision fermentation to produce bioactive proteins found in human breastmilk—has raised a $45 million series B round led by Avidity Partners. Additional investment came from Spark Capital, Ingeborg I...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In